Medical cannabis patients showed changes in prescription controlled substance use over time
Individual-level observational data showed that medical cannabis use was associated with changes in prescription controlled substance use, including potential opioid-sparing effects, but also raised questions about sedative hypnotic interactions.
Quick Facts
What This Study Found
Medical cannabis participants showed changes in controlled substance prescription patterns. While potential opioid-sparing effects were observed, the data also suggested interactions with sedative hypnotic use that could affect overdose risk.
Key Numbers
Individual-level data combining medical cannabis use with prescription controlled substance records. Opioid-sparing effects observed alongside changes in sedative hypnotic patterns.
How They Did This
Observational study combining individual-level data on medical cannabis use with prescription controlled substance records. Analyzed changes in opioid, sedative hypnotic, and other controlled substance use patterns.
Why This Research Matters
The opioid-sparing narrative focuses on potential benefits, but medical cannabis may also affect use of other controlled substances in ways that increase or decrease risk. Individual-level data provides more granular insight than population studies.
The Bigger Picture
Medical cannabis does not exist in a vacuum. Patients using medical cannabis are often also taking other controlled substances. Understanding how cannabis affects the full medication profile, not just opioids, is essential for assessing net risk and benefit.
What This Study Doesn't Tell Us
Observational design without randomization. Cannot attribute prescription changes to cannabis use versus other factors. Self-selection into medical cannabis. Limited ability to assess clinical outcomes (pain control, function) alongside prescription changes.
Questions This Raises
- ?Does medical cannabis reduce or increase overall overdose risk when considering all controlled substance interactions?
- ?Should medical cannabis prescribing guidelines address concurrent sedative hypnotic use?
Trust & Context
- Key Stat:
- Individual-level data showed opioid-sparing effects plus sedative hypnotic changes
- Evidence Grade:
- Individual-level observational data is more informative than ecological data but still cannot establish causation without randomization.
- Study Age:
- Published 2023.
- Original Title:
- Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use.
- Published In:
- Cannabis and cannabinoid research, 8(5), 933-941 (2023)
- Authors:
- Williams, Arthur Robin, Mauro, Christine M(5), Feng, Tianshu, Waples, Josef, Martins, Silvia S, Haney, Margaret
- Database ID:
- RTHC-05027
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Does medical cannabis reduce the need for other medications?
This study found medical cannabis use was associated with changes in prescription controlled substance patterns, including some opioid reduction. However, changes in sedative hypnotic use were also observed, which could have its own safety implications. The net effect on patient safety is complex.
Can medical cannabis be dangerous when combined with other medications?
Cannabis can interact with other substances, particularly sedatives and opioids, potentially increasing risks like excessive sedation or respiratory depression. This study highlights the importance of monitoring the full medication profile, not just opioid prescriptions, when patients use medical cannabis.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05027APA
Williams, Arthur Robin; Mauro, Christine M; Feng, Tianshu; Waples, Josef; Martins, Silvia S; Haney, Margaret. (2023). Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use.. Cannabis and cannabinoid research, 8(5), 933-941. https://doi.org/10.1089/can.2021.0212
MLA
Williams, Arthur Robin, et al. "Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use.." Cannabis and cannabinoid research, 2023. https://doi.org/10.1089/can.2021.0212
RethinkTHC
RethinkTHC Research Database. "Adult Medical Cannabinoid Use and Changes in Prescription Co..." RTHC-05027. Retrieved from https://rethinkthc.com/research/williams-2023-adult-medical-cannabinoid-use
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.